Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000238633 | SCV000297115 | benign | not specified | 2015-08-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000892394 | SCV001036262 | likely benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000892394 | SCV001146203 | likely benign | not provided | 2018-09-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000892394 | SCV001862698 | benign | not provided | 2020-01-28 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270076 | SCV002554899 | benign | Autosomal dominant nonsyndromic hearing loss 56 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000892394 | SCV005225449 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003977706 | SCV004792330 | benign | TNC-related disorder | 2019-10-18 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |